Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis

Role of interleukins in the pathogenesis of pulmonary fibrosis

(2021) Yi Xin She et al.   Cell Death Discovery

COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts

(2021) Alison E. John et al.   IMMUNOLOGICAL REVIEWS

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study

(2021) Ki Kwang Oh et al.   MEDICAL HYPOTHESES

Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?

(2020) Anuruddha Abeygunasekera et al.   MEDICAL HYPOTHESES

A new diethylcarbamazine formulation (NANO-DEC) as a therapeutic tool for hepatic fibrosis

(2018) Gabriel Barros Rodrigues et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis

(2017) Maria Eduarda Rocha de França et al.   INFLAMMOPHARMACOLOGY

Common pathway signature in lung and liver fibrosis

(2016) Eugene Makarev et al.   CELL CYCLE

Diethylcarbamazine: Possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice

(2015) Gabriel Barros Rodrigues et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Anti-inflammatory effects of diethylcarbamazine: A review

(2014) Christina Alves Peixoto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Immunomodulatory effect of diethylcarbamazine in mice infected with Nocardia brasiliensis

(2014) M. García-Hernández et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Diethylcarbamazine Reduces Chronic Inflammation and Fibrosis in Carbon Tetrachloride- (CCl4-) Induced Liver Injury in Mice

(2014) Sura Wanessa Santos Rocha et al.   MEDIATORS OF INFLAMMATION

Diethylcarbamazine Attenuates the Development of Carrageenan-Induced Lung Injury in Mice

(2014) Edlene Lima Ribeiro et al.   MEDIATORS OF INFLAMMATION

Immunomodulatory activity of diethylcarbamazine on humoral, cellular cytokine response and respiratory burst in BALB/c mice

(2012) Carlos E. Medina-De la Garza et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY